Snowball logo
logo
ESPR_logo

Esperion Therapeutics, Inc

$3.18$0.00Β  (0%)
πŸ’‘ Click on a row in the table to make it appear on the graph
πŸ“Š Compare financials of multiple companies on the same chart
This feature is available with our premium plans. Upgrade to unlock the full potential of Snowball Analytics and be on top of your investments!
20212022202320242025TTM
Revenue
Total revenue
78.4575.47116.3332.3403.1418.2
COGS
14.2226.9743.2768.6129.2146.4
Gross Profit
64.2348.5173.07263.7273.9271.9
Operating Expenses & Income
Operating Income
(226.7)(179.5)(155.6)54.460.2775.79
Total Operating Expenses
291228228.6209.3213.6196.1
R&D Expenses
106118.986.1146.2447.8544.28
Selling General & Admin Expenses
171.397.78126.9137.6165.8165.9
Earnings from Continuing Operations
Interest Expense
(46.35)(56.81)(58.98)(59.25)(84.6)(84.97)
Interest Income
------
Income Tax Expense
49.7254.16(0.003895)(51.74)1.8411.841
Net Income
Net Income
(269.1)(233.7)(209.2)(51.74)(22.68)(7.423)
Supplemental
EBIT
(222.8)(176.8)(150.3)7.50663.7639.79
EBITDA
(222.1)(176.3)(150.1)7.56963.8739.9
In millions of USD, except % and values per 1 share